Pharmaron Beijing Co., Ltd. (SHE:300759)
40.28
-1.27 (-3.06%)
Sep 11, 2026, 3:04 PM CST
Pharmaron Beijing Revenue
Pharmaron Beijing had revenue of 4.02B CNY in the quarter ending June 30, 2026, with 20.19% growth. This brings the company's revenue in the last twelve months to 15.25B, up 16.30% year-over-year. In the year 2025, Pharmaron Beijing had annual revenue of 14.10B with 14.82% growth.
Revenue (ttm)
15.25B
Revenue Growth
+16.30%
P/S Ratio
4.46
Revenue / Employee
558.26K
Employees
27,316
Market Cap
67.95B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.10B | 1.82B | 14.82% |
| Dec 31, 2024 | 12.28B | 737.78M | 6.39% |
| Dec 31, 2023 | 11.54B | 1.27B | 12.39% |
| Jan 1, 2023 | 10.27B | 2.82B | 37.92% |
| Dec 31, 2021 | 7.44B | 2.31B | 45.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsPharmaron Beijing News
- 22 days ago - Pharmaron Beijing Quarterly report: Q2 2026 - Filings
- 22 days ago - Pharmaron Beijing Quarterly report: Q2 2026 - Filings
- 4 months ago - Pharmaron Beijing Quarterly report: Q1 2026 - Filings
- 5 months ago - Pharmaron Beijing Annual report: Q4 2025 - Filings
- 10 months ago - Pharmaron Beijing Quarterly report: Q3 2025 - Filings